Alternative splicing transitions have been identified recently as a conserved component of vertebrate heart remodeling during postnatal development. Here we report that the targeted deletion of Dicer, specifically in adult mouse myocardium, reveals the role of microRNAs (miRNAs) in regulating networks of postnatal splicing transitions and in maintaining adult splicing programs. We demonstrate a direct role for miR-23a/b in the dramatic postnatal down-regulation of CUGBP and ETR-3-like factor (CELF) proteins that regulate nearly half of developmentally regulated splicing transitions in the heart. These findings define a hierarchy in which rapid postnatal upregulation of specific miRNAs controls expression of alternative splicing regulators and the subsequent splicing transitions of their downstream targets.
MicroRNAs (miRNAs) are key components of posttranscriptional gene regulation with diverse roles in tissue development, differentiation, and homeostasis (van Rooij et al. 2007; Zhao et al. 2007; Bartel 2009 ). Mature miRNAs are formed by two sequential processing reactions: Primary transcripts of miRNA genes are first cleaved into hairpin-containing intermediates (pre-miRNAs) by the Drosha microprocessor complex, and pre-miRNAs are then processed into mature miRNAs by Dicer (Kim 2005) . While miRNA-mediated regulation stimulates quantitative changes in protein and mRNA expression (Baek et al. 2008; Selbach et al. 2008) , alternative pre-mRNA splicing controls qualitative gene output in the expression of diverse mRNA isoforms (Blencowe 2006) . Recent genome-wide studies revealed that >90% of human intron-containing genes are alternatively spliced, and more than half of alternative splicing events differ between tissues, revealing an extensive level of regulation Pan et al. 2008; Wang et al. 2008) .
The mammalian heart undergoes a period of dramatic remodeling during the first 3 wk after birth that requires transcriptional and post-transcriptional regulatory programs not yet fully understood (Xu et al. 2005; Olson 2006) . We recently identified a conserved set of alternative splicing transitions during mouse heart development, and demonstrated that nearly half are responsive to the CUGBP and ETR-3-like factor (CELF) family of splicing regulators . Two CELF proteins, CUGBP1 and CUGBP2, are highly expressed in the fetal heart, but are down-regulated >10 fold within 3 wk after birth without a change in mRNA levels.
Here we used targeted deletion of the Dicer gene specifically in adult mouse myocardium to test the role of miRNAs in the mechanism of CELF protein downregulation during postnatal development. Both CELF proteins were dramatically up-regulated within 2 d of Dicer knockout, as was a subset of five other splicing regulators, while spliceosomal components and an additional set of splicing regulators were not affected. Using multiple independent assays, including antagomir delivery to adult mice, we demonstrate a direct role for miR23a/b in the postnatal down-regulation of the two CELF proteins. Using a data set of postnatal splicing transitions for which we identified cognate regulators, we demonstrate splicing networks that are and are not miRNAdependent in both the Dicer knockout and antagomirtreated hearts. The effects of the Dicer knockout are specific, as neither the expression of splicing regulators nor their target splicing events are affected in three different mouse models of cardiomyopathy. Our results define an important hierarchy in which miRNA expression controls expression of alternative splicing regulators during a critical period of heart development.
Results and Discussion
The two CELF paralogs expressed in the heart, CUGBP1 and CUGBP2, exhibit a respective 10-fold and 18-fold decrease in protein during the first 2 wk after birth without a decrease in mRNA levels, indicative of posttranscriptional regulation . CUGBP1 is stabilized by phosphorylation, which decreases during postnatal heart development (Supplemental Fig. 1 ; ). In contrast, CUGBP2 exhibits no change in its phosphorylation state during postnatal development, indicating a different mechanism for its down-regulation (Supplemental Fig. 1 ).
To determine whether miRNAs are required for repression of CUGBP1 and CUGBP2 proteins in adult hearts, we generated tamoxifen (Tam)-inducible, heart-specific Dicer knockout mice using a Cre-loxP approach (Supplemental Fig. 2A ). Mice contain a single Dicer gene that is required to generate mature miRNAs (Birchler and Kavi 2008) . Inducible ablation of Dicer in adult hearts overcame previously described early developmental defects (Chen et al. 2008 ) and allowed timed analysis to distinguish primary effects from secondary compensatory changes. PCR analysis on DNA from heart tissue of Dicer homozygous floxed (f/f); MerCreMer (MCM) mice showed recombination only upon Tam treatment, indicating minimal recombination in uninduced mice (Supplemental Fig.  2B ). Western blot analysis showed a more than threefold decrease in Dicer protein 8 wk following Tam treatment (Fig. 1A) . The loss of mature miRNAs and accumulation of unprocessed precursors confirmed the functional loss of Dicer (Fig. 1B) . Residual levels of Dicer protein and mature miRNAs (Fig. 1A,B ) in recombined heart tissue were most likely from noncardiomyocytes as well as incomplete recombination and/or long-lived miRNAs.
The cardiomyocyte-specific loss of Dicer in adult mice resulted in dilated cardiomyopathy and premature death within 10 wk of Tam treatment (Fig. 1C) . Histology and echocardiography studies revealed dilation of the left ventricle, thinning of the left ventricular wall, and reduced fractional shortening accompanied by systolic and diastolic dysfunction in Dicer f/f ; MCM mice treated with Tam ( Fig. 1D; Supplemental Fig. 3A-D) . We also detected profound myofiber disarray (Fig. 1E) , increased heartto-body weight ratios, widespread apoptosis (Supplemental Fig. 3E,F) , myocyte hypertrophy, inflammatory cell infiltration, and focal areas of mild interstitial fibrosis (data not shown). Tam-treated Dicer f/f mice and MCM controls showed no changes in several parameters examined (Supplemental Fig. 4A,B ; data not shown). Similar effects have been described 1 wk after Tam induction (da Costa Martins et al. 2008) .
Consistent with a role for miRNA-mediated repression in the adult heart, CUGBP1 and CUGBP2 proteins were strongly up-regulated in heart tissue from Dicer knockout mice 8 wk following Tam treatment compared with uninduced mice (Fig. 1F) . To determine whether CELF protein up-regulation was a general response to cardiac injury, we assayed CUGBP1 and CUGBP2 protein levels in three different mouse models of heart disease (Sano et al. 2002; Braz et al. 2004) . While each of these models exhibited altered expression of marker genes, CUGBP1 and CUGBP2 levels were unaffected (Supplemental Fig.  4C ). Consistent with elevated CELF protein expression in Dicer knockout hearts, previously identified CUGBP1 target exons that switch their splicing pattern during normal postnatal heart development reverted to the embryonic pattern, but were unaffected in the other three models of heart disease ( Fig. 1G ; Supplemental Fig. 4D ). Several constitutive and alternative exons that are not regulated during postnatal heart development showed no changes in Dicer knockout hearts (Supplemental Fig. 5 ). We conclude that CELF protein induction and the subsequent reversion to embryonic splicing patterns is due to the loss of miRNAs rather than a secondary response to cardiac injury.
We found that CUGBP1 and CUGBP2 up-regulation in Dicer knockout hearts was relatively rapid, and was observed within 48 h after the last dose of Tam injections ( Fig. 2A) . Real-time RT-PCR results (Fig. 2B) confirmed that CUGBP1 and CUGBP2 mRNA levels in Dicer knockout hearts 48 h after Tam treatment remain constant despite striking changes in protein expression. Intriguingly, several other splicing regulators were also up-regulated rapidly after Dicer loss, including Fox-1, Fox-2, PTB, Tia1, and hnRNP H ( Fig. 2A) . Fox-2 showed a dramatic change in the ratio of its protein isoforms in response to the loss of Dicer, suggestive of a change in splicing pattern. In contrast, the expression of MBNL1, ASF/SF2, hnRNP C, and hnRNP L splicing regulators was unaffected ( Fig. 2A) . Each bar represents mean 6 SD (of four biological replicates) for the percent inclusion of the specified exon. P < 0.05; asterisk (*) indicates significantly different from wild-type mice.
In addition, none of the basal spliceosomal components tested showed a change in steady-state protein levels in Dicer knockout hearts (Fig. 2C) . Therefore, these results identified a specific set of auxiliary splicing factors that are under regulatory control of miRNAs in the mouse heart. Inflammatory cells were detected by 48 h after Dicer loss (data not shown), and we considered the possibility that these infiltrating cells were the source of the increased splicing factors. Immunohistochemistry for CUGBP1, CUGBP2, and Fox-1 in Dicer knockout hearts 48 h after Tam treatment demonstrated nuclear localization (Fig.  2D , black arrows, top panel). Coimmunofluorescent staining of CUGBP1 with the cardiomyocyte marker desmin confirmed that CUGBP1 protein was elevated only in the nuclei of cardiomyocytes (Fig. 2D , white arrows) but not other cell types (Fig. 2D , white circle, third panel from top). CUGBP1 expression in Dicer f/f ; MCM mice without Tam treatment remained low (Fig. 2D , second panel from top). Thus, we conclude that the rapid up-regulation of specific splicing factors following Dicer gene ablation is specific to cardiomyocytes.
To determine whether early up-regulation of CELF proteins resulted in the embryonic splicing program in adult hearts, we examined splicing of five CUGBP1-regulated exons along with three MBNL1-regulated exons as controls for a splicing regulator not affected by Dicer knockout. As shown in Figure 2 , E and F, all eight splicing events underwent robust splicing shifts between embryonic day 14 (E14) and the adult heart. However, only splicing events regulated by CUGBP1 and not those regulated by MBNL1 shifted to the embryonic pattern in Dicer knockout hearts, consistent with the respective changes in protein expression ( Fig. 2A ,E,F). These results provide strong evidence that, by regulating key splicing factors, miRNAs coordinate developmental transitions in alternative splicing in the postnatal heart. miRNA-based down-regulation of CELF protein expression during postnatal development could result from either a switch to longer 39-untranslated regions (UTRs) introducing new miRNA-binding sites Ji et al. 2009 ), or up-regulation of specific miRNAs that target CUGBP1 and CUGBP2 mRNAs. Northern blot analysis of CUGBP1 and CUGBP2 mRNAs from E14 and adult mouse heart RNA revealed the absence of large structural changes in these mRNAs during development (Supplemental Fig. 6 ). Three different algorithms were used to identify candidate miRNAs that potentially regulate CUGBP1 and CUGBP2 expression. A number of miRNAs targeting both CUGBP1 and CUGBP2 were predicted by each program, but only miR-96 and miR-23 were predicted by all three algorithms. Consistent with earlier reports (Chen et al. 2008) , we found that miR-96 is not expressed in the heart (Fig. 3B) , and therefore focused on miR-23. miR-23 includes miR-23a and miR-23b, which are transcribed from different chromosomes, have identical seed sequences, and differ by only 1 nucleotide on their 39 ends. There are three conserved miR-23a/b seed matches in the 39-UTR of CUGBP1 and two in CUGBP2 (Fig. 3A) . Strikingly, miR-23a/b expression displays an inverse temporal relationship to CUGBP1 and CUGBP2 protein expression during a narrow period of postnatal heart development. For instance, between postnatal days 6 and 14, miR-23a/b levels increase nearly fourfold, whereas CUGBP1 and CUGBP2 levels decline nearly fivefold and fourfold, respectively (Fig. 3B,C) . Cold Spring Harbor Laboratory Press on March 18, 2010 -Published by genesdev.cshlp.org Downloaded from
To determine whether CUGBP1 and CUGBP2 transcripts are regulated directly by miR-23a/b, we constructed reporter plasmids in which 39-UTR segments containing each of the three (CUGBP1) or two (CUGBP2) predicted binding sites were cloned downstream from a luciferase ORF, with or without mutations that would disrupt the predicted miRNA interaction (Supplemental Fig. 7) . We overexpressed miR-23b or a nonsilencing control miRNA (NS) in human embryonic kidney (HEK) 293T cells using lentiviral constructs that coexpress TurboRed fluorescent protein. TurboRed fluorescence indicated a high efficiency of infection (Supplemental Fig. 8A ) and miR-23b overexpression was confirmed using Northern blots (Supplemental Fig. 8B ). miR-23b significantly repressed luciferase activity of each of the five constructs containing wild-type CUGBP1 and CUGBP2, but not the mutant reporter constructs, while cotransfection with NS had no effect (Fig.  3D ). These results demonstrate a direct functional interaction between miR-23b and each of these regions within the 39-UTR of CUGBP1 and CUGBP2.
To determine whether miR-23b can suppress endogenous CELF protein expression, we overexpressed miR-23b in HL-1 mouse cardiomyocytes (Claycomb et al. 1998 ). Both CUGBP1 and CUGBP2 are abundantly expressed in these cells, consistent with low expression of endogenous miR-23a/b and expression of the embryonic splicing program for nine out of the 10 developmentally regulated and CUGBP1-responsive splicing events that were screened (data not shown). We overexpressed miR-23b or NS using a lentivirus expression vector (Fig. 3E) , and assayed steadystate protein and mRNA levels for CUGBP1 and CUGBP2 by Western blotting and real-time RT-PCR, respectively. CELF protein levels (Fig. 3F ), but not mRNA levels (Fig.  3G) , were significantly decreased in the presence of miR23b when compared with NS. Consistent with protein down-regulation, CUGBP1 pre-mRNA targets shifted from embryonic to adult splicing patterns in HL-1 cells overexpressing miR-23b (Fig. 3H) . Furthermore, miR-23b and miR-23a overexpression in HEK293T cells also resulted in strong down-regulation of CELF protein, demonstrating that miR-23 regulation of CELF proteins is conserved between mice and humans, and suggesting redundancy between miR-23a and miR-23b in regulation of CELF proteins (Supplemental Figs. 8C, 9) .
To test whether miR-23a/b are necessary for suppressing CELF protein expression in adult hearts, we infused a miR23a or a negative control (NC) antagomir in wild-type adult mice for systemic delivery to the heart as described previously (Lin et al. 2009 ). The 25 and 75 mg/kg doses of miR-23a antagomir produced 50% and 65% knockdowns, respectively, of both miR-23a and miR-23b without causing any overt phenotype ( Fig. 4A ; data not shown). Administration of the miR-23a antagomir resulted in a significant increase in CUGBP1 and CUGBP2 protein levels in adult hearts (Fig. 4C,D) without affecting their respective mRNA levels (Fig. 4B) . Importantly, the increase in CELF proteins correlated directly with an adult to embryonic shift in the splicing of CUGBP1 pre-mRNA targets (Fig.  4E) . In contrast, miR-23a/b knockdown had no effect on the splicing of three MBNL1-regulated exons (Supplemental Fig. 10) , demonstrating specificity to CELF pre-mRNA targets. These data indicate that postnatal up-regulation of miR-23a/b suppresses CUGBP1 and CUGBP2 protein expression in adult hearts via direct binding to their respective 39-UTRs, resulting in a physiological shift in the alternative splicing of a subset of splicing events.
miRNA-based gene silencing and alternative splicing have emerged as two key post-transcriptional mechanisms that function on a genome-wide scale to regulate tissue development and differentiation (Blencowe 2006; Bartel 2009 ). The interplay between the miRNA and splicing regulation has been demonstrated in cell culture models in which large-scale changes in splicing occur due to a switch in the expression of splicing regulators PTB/nPTB that is controlled by cell-and tissue-specific miRNAs (Boutz et al. 2007; Makeyev et al. 2007 ). Here we identified a posttranscriptional regulatory network operative during the critical period of postnatal heart development in which coordination of a predominantly conserved set of splicing transitions are driven to the adult pattern, at least in part by miRNA-mediated regulation of splicing factor expression. Most of the auxiliary splicing regulators but none of the basal splicing components examined demonstrated Dicer-dependent regulation, indicating a large potential for linked programs of post-transcriptional regulation. These results also demonstrate that, in addition to modulating splicing transitions during postnatal heart development, miRNAs also maintain appropriate expression of splicing regulators in adult hearts. Disruption of this regulation could cause previously unrecognized mechanisms of disease. For example, aberrant up-regulation of CUGBP1 in adult hearts is associated with myotonic dystrophy in which expression of embryonic splicing patterns in adult tissues lead to specific disease features (Cooper et al. 2009 ).
Materials and methods

Animal models
Mice homozygous for the Dicer f/f alleles, were crossed with Tam-inducible MCM transgenic mice that express Cre recombinase protein under the control of the cardiac-specific a-myosin heavy-chain (MHC) promoter (Sohal et al. 2001; Yi et al. 2006 ). Cre-mediated recombination was induced in 2-to 4-mo-old mice by intraperitoneal injection of 20 mg/kg Tam (Tam; Sigma-Aldrich) once daily for five consecutive days. Dicer f/f ; MCM mice treated with vehicle alone (ÀTam) were used as controls. In vivo inhibition of miR-23 was performed by infusing a miR-23a antagomir (25 or 75 mg/kg per day) for 1 wk using Alzet osmotic pumps as described previously (Lin et al. 2009 ). NC antagomir (59-AGUACUUUUGUGUAGUACAA-39) served as a NC. All experiments were conducted in accordance with the NIH Guide for the Use and Care of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine.
Cell culture and transfections
HL-1 cells were cultured on gelatin (0.02%, w/v)/fibronectin (10 mg/mL)-coated plates and were maintained in Claycomb medium (JRH Biosciences) supplemented with 10% fetal bovine serum (JRH Biosciences), 2 mM L-glutamine, 0.1 mM norepinephrine, 100 U/mL penicillin, and 100 mg/mL streptomycin (Life Technologies) as described previously (Claycomb et al. 1998 ). HEK293T cells were cultured in high-glucose (4.5 g/L) DMEM supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 13 sodium pyruvate, 100 U/mL penicillin, and 100 mg/mL streptomycin. Viral stocks for miR-23b and a NS (contains a random nontargeting sequence; Open Biosystems) were produced using the lentiviral packaging plasmids psPAX2 and pMD2.G (Addgene, Inc.), concentrated and titered as per the manufacturer's instructions. The HL-1 cells were infected in T25 flasks with miR23b or NS viral stocks in the presence of 8 mg/mL polybrene. After 48 h of selection in 2 mg/mL puromycin selection media, cells were harvested to isolate total RNA or proteins. For transient transfections, miRNA mimics for NS, miR-22, or miR-23a were purchased from Dharmacon and were transfected at 100 nM final concentration using the manufacturer's instructions.
Protein and mRNA expression analysis
Protein expression by Western blot analysis and RNA expression by semiquantitative and real-time RT-PCR was performed by using standard procedures. Antibody and primer information is provided in the Supplemental Material.
RT-PCR splicing analysis
Splicing analysis by RT-PCR was performed using unique primers around potential splicing regions as described previously ).
Histology, immunohistochemistry, Northern blotting, luciferase assay, and cardiac function analysis
Details of histology, immunohistochemistry, Northern blotting, luciferase assay, and cardiac function analysis are provided in the Supplemental Material.
Statistics
Values are presented as mean 6 SD. Statistical significance was determined using two-tailed Student's t-test or one-way ANOVA followed by post hoc Tukey's multiple range test (P < 0.05). Figure S1 . 2D/western blot analysis of CUGBP1 and CUGBP2 phosphorylation during post-natal heart development. 100μg of total protein from post-natal day 2, 6, 14 and 21 hearts were prepared in urea buffer, separated using Ettan IPGphor Isoelectric Focusing System (GE Healthcare) followed by 10% SDS-PAGE and western blotting using CUGBP1 and CUGBP2 antibodies as described previously ). development show no significant change in percent inclusion levels upon targeted deletion of dicer in adult heart. The assay parameters and primer sequences were used as previously described . Twenty five micrograms of total RNA extracted from embryonic day (E) 14 and adult heart was resolved on 1% agarose gel, transferred on to GeneScreen nylon membranes and probed for CUGBP1 and CUGBP2 transcripts. 28S and 18S rRNA served as loading controls. 
2D/Western analysis of CUGBP1 and CUGBP2
For 2D gel analysis, mouse heart tissues were immediately frozen in liquid nitrogen, and powderized using a mortar and a pestle. Powderized tissues were resuspended in 2D urea buffer . Protein concentrations of the cleared lysates were determined by the Bradford assay (BioRad). The first dimension was performed using 100μg proteins on an Ettan IPGphor Isoelectric Focusing System (GE Healthcare) followed by 10% SDS-PAGE and western blotting as described previously ).
Cardiac Function
Transthoracic echocardiography was performed on lightly anesthetized mice using 1.5% isoflurane mixed with 95% oxygen. Mice were stabilized on a heated platform and taped to ECG electrodes. Evaluation of cardiac function was done using a Visual Sonics Vivo 770 ultra sound using a 30 MHz probe. Two dimensional guided M-mode tracings were recorded in both parasternal long and short axis views at the level of papillary muscles. Image analysis was done using Visual Sonics software version 2.3.0.
Histology, Immunohistochemistry and TUNEL assays
Heart tissues were fixed in 4% paraformaldehyde for 1-2 days, rinsed in PBS, dehydrated, and then embedded in paraffin. Five micron sections were cut, transferred onto glass slides, dewaxed and stained with H&E or subjected to immunohistochemistry.
Endogenous peroxidase activities were quenched with a 0.6% hydrogen peroxide solution.
After blocking for 1 hr (5% goat serum in PBS containing 0.25% Triton X-100), sections were incubated for 48h with primary monoclonal antibodies against CUGBP1 (3B1; at 2 μg/mL), CUGBP2 (1H2; at 3 μg/mL) and Fox-1 (described in ; at 4 μg/mL) at 4 ο C. Vectastain-Elite ABC reagent kit and biotinylated goat anti-mouse antibody (1:500) were used to visualize specific binding (Vector Laboratories, Burlingame, CA, USA).
For co-immunofluorescence studies, sections were blocked for 1h at room temperature followed by 48h incubation with a mixture of primary antibodies (monoclonal anti-CUGBP1 at 2 μg/mL; and polyclonal anti-desmin at 1 μg/mL) at 4 ο C. Sections were then washed with PBS, and incubated with secondary antibodies (AlexaFluor-594 goat anti-rabbit IgG at 1:1000 and AlexaFluor-488 goat anti-mouse IgG at 1:500) for 2 hours.
After several washes with PBS, sections were mounted with medium containing DAPI (1.5 mg/ml; Vector) and subjected to fluorescence microscopy. Apoptosis was evaluated by TUNEL assays with the Fluoroscein-In situ cell death detection kit (Roche) according to the manufacturer's instructions. Quantitation was performed by choosing ten random fields on each section and counting green fluorescence-positive cells and total cells stained with DAPI.
Northern blotting
Twenty five micrograms of total RNA was loaded in each lane run on a 15%
acrylamide denaturing gels and transferred to GeneScreen Plus nylon membranes (Perkin Elmer). The blots were cross-linked (Stratalinker) and pre-hybridized at 42°C in Ultrahyboligo buffer (Ambion) for 2h. Oligonucleotide probes perfectly complementary to the mature miRNA sequences were labeled with a-32 P dATP using Starfire Oligos Kit (IDT) and hybridized to the membranes overnight at 42°C. After appropriate washing in 1x SSC in 1% SDS solution at 42°C, the blots were exposed and quantified by PhosphorImager analysis. All membranes were stripped and reprobed for U6 RNA as a loading control.
Northern blotting of CUGBP1 and CUGBP2 was performed using gene-specific probes amplified by RT-PCR.
RT-PCR splicing analysis
Total RNA (0.3-0.5 µg) was used for RT reaction. PCR analysis was performed using unique primers around potential splicing regions as described previously. Primer sequences for detecting alternative splicing of exon 4 and 5 of cTnT, exon 21 of Ank2, exon 16 of Mtmr3, exons 6 and 23 of Sorbs1 and exon 5 of Mbnl1 were described previously . Percentage exon inclusion was calculated using Kodak
Gel logic 2200 and Molecular Imaging Software as: [(exon inclusion band)/ (exon inclusion band + exon exclusion band) X 100].
miRNA prediction and Luciferase reporter assays
Putative miRNA seed sequences in the CUGBP1 and CUGBP2 3'-UTRs (recovered from GenBank) were predicted by three different algorithms-TargetScan (http://www.targetscan.org/), Pictar (http://pictar.mdc-berlin.de/), and DianaMicroT (http://diana.cslab.ece.ntua.gr/). DNA fragments containing portions of CUGBP1 and CUGBP2 3'-UTRs encompassing wild type or mutated miR-23 putative binding sites were cloned into pMIR-REPORT vector (Ambion). Briefly, HEK293T cells were independently transfected six times with plasmids using Fugene 6 (Roche) according to the manufacturer's instructions. Where indicated, miR-23b or a non silencing control (Open Biosystems) lentiviral plasmid was cotransfected along with pCMV-lacZ as a transfection control. Forty-eight hours after transfection, cell extracts were assayed for luciferase expression using the luciferase assay kit (Promega). Relative reporter activities were calculated as luminescence units normalized for β-galactosidase expression.
